In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $0.44 in the prior trading day, Passage Bio Inc (NASDAQ: PASG) closed at $0.4, down -9.86%. In other words, the price has decreased by -$9.86 from its previous closing price. On the day, 1.25 million shares were traded. PASG stock price reached its highest trading level at $0.4399 during the session, while it also had its lowest trading level at $0.3502.
Ratios:
Our goal is to gain a better understanding of PASG by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.74 and its Current Ratio is at 3.74. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.46.
On September 03, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 07 ’25 when OrbiMed Private Investments VI bought 259,000 shares for $0.43 per share.
ORBIMED ADVISORS LLC sold 231,600 shares of PASG for $81,060 on Jun 24 ’25. The 10% Owner now owns 6,418,400 shares after completing the transaction at $0.35 per share. On Jun 26 ’25, another insider, ORBIMED ADVISORS LLC, who serves as the 10% Owner of the company, sold 213,257 shares for $0.33 each. As a result, the insider received 70,375 and left with 6,066,343 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PASG now has a Market Capitalization of 24703950 and an Enterprise Value of -13363046.
Stock Price History:
The Beta on a monthly basis for PASG is 1.82, which has changed by -0.5765958 over the last 52 weeks, in comparison to a change of 0.11844492 over the same period for the S&P500. Over the past 52 weeks, PASG has reached a high of $1.33, while it has fallen to a 52-week low of $0.26. The 50-Day Moving Average of the stock is 5.34%, while the 200-Day Moving Average is calculated to be -23.79%.
Shares Statistics:
The stock has traded on average 300.82K shares per day over the past 3-months and 475780 shares per day over the last 10 days, according to various share statistics. A total of 62.15M shares are outstanding, with a floating share count of 53.21M. Insiders hold about 14.38% of the company’s shares, while institutions hold 43.12% stake in the company. Shares short for PASG as of 1749772800 were 1781795 with a Short Ratio of 5.92, compared to 1747267200 on 1736311. Therefore, it implies a Short% of Shares Outstanding of 1781795 and a Short% of Float of 3.9.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Investors are eagerly awaiting the insights provided by 4.0 analysts currently analyzing and rating the stock of Passage Bio Inc (PASG).The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.15 and low estimates of -$0.26.
Analysts are recommending an EPS of between -$0.32 and -$0.98 for the fiscal current year, implying an average EPS of -$0.73. EPS for the following year is -$0.75, with 3.0 analysts recommending between -$0.42 and -$1.35.
